|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1650 Diagonal Road |
Address2 |
|
| City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1386-12
|
||||||||
|
6. House ID# 321810000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Thomas Radder |
Date | 1/20/2023 2:54:24 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
December 22, 2022, Alliance of Specialty Medicine letter to Representative Richard Hudson expressing our support for H.R. 9584, the Accessible Care by Curbing Excessive lawSuitS Act of 2022, which sets conditions for lawsuits arising from health care liability claims.
December 21, 2022, Alliance of Specialty Medicine letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer and Senate Republican Leader Mitch McConnell expressing our concern about pending cuts to Medicare physician payment rates in the Fiscal Year 2023 Omnibus Appropriations bill.
December 20, 2022, coalition letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, Senate Republican Leader Mitch McConnell, Senators Ron Wyden and Mike Crapo, and Representatives Frank Pallone and Cathy McMorris Rodgers, urging Congress to modify the omnibus legislation and stop the full 4.5 percent cut to Medicare physician payment rates for Fiscal Year 2023.
December 16, 2022, Alliance of Specialty Medicine letter to Senator John Kennedy expressing our support for S. 5194, the Protecting Medicare Patients and Physicians Act, which would mitigate pending cuts to Medicare physician payment rates in Fiscal Year 2023.
December 6, 2022, Alliance of Specialty Medicine letter to Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure in response to CMS request for information (RFI) soliciting public comment on establishing a National Directory of Healthcare Providers & Services (NDH).
December 5, 2022, coalition letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer and Senate Republican Leader Mitch McConnell urging Congress to prevent the entire 4.5 percent reduction to Medicare physician payment rates from being implemented on January 1, 2023.
November 21, 2022, coalition letter to Federal Trade Commission (FTC) Chair Lina Khan commenting on the FTCs advance notice of proposed rulemaking (ANPR) entitled Trade Regulation Rule on Commercial Surveillance and Data Security, which pertains to clinical data registries.
November 2, 2022, coalition letter to Representatives Richard Neal, Kevin Brady, Frank Pallone, Cathy McMorris Rodgers, Lucille Roybal-Allard and David Joyce expressing our opposition to H.R. 8812, the Improving Care and Access to Nurses Act or the I CAN Act. This legislation would expand the scope of practice for non-physician practitioners (NPPs) under Medicare and Medicaid.
October 31, 2022, coalition letter to Representatives Ami Bera, MD, Larry Bucshon, MD, Kim Schrier, MD, Michael Burgess, MD, Earl Blumenauer, Brad Wenstrup, DPM, Bradley Schneider and Mariannette Miller-Meeks, MD in response to a congressional request for information (RFI) on the Centers for Medicare & Medicaid Services (CMS) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
October 28, 2022, letter to Representatives Ami Bera, MD, Larry Bucshon, MD, Kim Schrier, MD, Michael Burgess, MD, Earl Blumenauer, Brad Wenstrup, DPM, Bradley Schneider and Mariannette Miller-Meeks, MD in response to a congressional request for information (RFI) on the Centers for Medicare & Medicaid Services (CMS) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, H.R. 8812, H.R. 6087, and in general.
Issues pertaining to prior authorization, related to H.R. 3173/H.R. 8487/S. 3018 and H.R. 7995, and in general.
Issues pertaining to the Early Hearing Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general.
Issues pertaining to Medicare physician reimbursement, related to H.R. 8800 and S. 5194, and in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to COVID-19, in general.
Issues pertaining to healthcare liability reform, related to H.R. 9584, and in general.
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation.
Issues pertaining to the "Magnet Injury Prevention Act," H.R. 8199/S. 4479.
Issues pertaining to clinical data registries, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
December 21, 2022, Alliance of Specialty Medicine letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer and Senate Republican Leader Mitch McConnell expressing our concern about pending cuts to Medicare physician payment rates in the Fiscal Year 2023 Omnibus Appropriations bill.
December 20, 2022, coalition letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, Senate Republican Leader Mitch McConnell, Senators Ron Wyden and Mike Crapo, and Representatives Frank Pallone and Cathy McMorris Rodgers, urging Congress to modify the omnibus legislation and stop the full 4.5 percent cut to Medicare physician payment rates for Fiscal Year 2023.
December 16, 2022, Alliance of Specialty Medicine letter to Senator John Kennedy expressing our support for S. 5194, the Protecting Medicare Patients and Physicians Act, which would mitigate pending cuts to Medicare physician payment rates in Fiscal Year 2023.
December 6, 2022, Alliance of Specialty Medicine letter to Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure in response to CMS request for information (RFI) soliciting public comment on establishing a National Directory of Healthcare Providers & Services (NDH).
December 5, 2022, coalition letter to Speaker Nancy Pelosi, House Republican Leader Kevin McCarthy, Senate Majority Leader Charles Schumer and Senate Republican Leader Mitch McConnell urging Congress to prevent the entire 4.5 percent reduction to Medicare physician payment rates from being implemented on January 1, 2023.
November 2, 2022, coalition letter to Representatives Richard Neal, Kevin Brady, Frank Pallone, Cathy McMorris Rodgers, Lucille Roybal-Allard and David Joyce expressing our opposition to H.R. 8812, the Improving Care and Access to Nurses Act or the I CAN Act. This legislation would expand the scope of practice for non-physician practitioners (NPPs) under Medicare and Medicaid.
October 31, 2022, coalition letter to Representatives Ami Bera, MD, Larry Bucshon, MD, Kim Schrier, MD, Michael Burgess, MD, Earl Blumenauer, Brad Wenstrup, DPM, Bradley Schneider and Mariannette Miller-Meeks, MD in response to a congressional request for information (RFI) on the Centers for Medicare & Medicaid Services (CMS) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
October 28, 2022, letter to Representatives Ami Bera, MD, Larry Bucshon, MD, Kim Schrier, MD, Michael Burgess, MD, Earl Blumenauer, Brad Wenstrup, DPM, Bradley Schneider and Mariannette Miller-Meeks, MD in response to a congressional request for information (RFI) on the Centers for Medicare & Medicaid Services (CMS) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, H.R. 8812, and in general.
Issues pertaining to prior authorization, related to H.R. 3173/H.R. 8487/S. 3018 and H.R. 7995, and in general.
Issues pertaining to the Early Hearing Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general.
Issues pertaining to Medicare physician reimbursement, related to H.R. 8800, S. 5194, and in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to COVID-19, in general.
Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues pertaining to tobacco control, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
|
Christopher |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues pertaining to increased funding for the Centers for Disease Control and Prevention's Office on Smoking and Health for fiscal year 2023, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Christopher |
Stewart |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |